Healthcare - Biotechnology - NASDAQ - US
$ 1.1201
-3.44 %
$ 2.29 M
Market Cap
-0.06
P/E
Price Target
Average
435.67%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
41.42%
Net Income
Estimate
73.16%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Dermata Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for DRMA of $6 , with forecasts ranging from a low of $6 to a high of $6 .
DRMA Lowest Price Target
Wall Street Target
6 USD
435.67%
DRMA Average Price Target
Wall Street Target
6 USD
435.67%
DRMA Highest Price Target
Wall Street Target
6 USD
435.67%
REVENUE FORECAST
Revenue Forecast Chart DRMA
EBIT FORECAST
EBIT Forecast Chart DRMA
NET INCOME FORECAST
Net Income Chart DRMA